ADAM17 is required for EGF-R–induced intestinal tumors via IL-6 trans-signaling
Stefanie Schmidt(Christian-Albrechts-Universität zu Kiel), Stefan Rose‐John(Christian-Albrechts-Universität zu Kiel)
Cited by 77
Related Papers
Interleukin-6 Family Cytokines
|Cold Spring Harbor Perspectives in Biology|2017|784
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
|Journal of Clinical Investigation|2011|677
Targeting IL-6 trans-signalling: past, present and future prospects
|Nature reviews. Immunology|2023|453
Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
|The Journal of Experimental Medicine|2010|273